New Testosterone, Steroid Labels To Warn Of Abuse, Dependence, FDA Says In Warning
SILVER SPRING, Md. — The Food and Drug Administration on Oct. 24 said it approved classwide labeling changes for all prescription testosterone products and anabolic androgenic steroids (AAS) to warn about...To view the full article, register now.
Already a subscriber? Click here to view full article